查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美 dPCR 和 qPCR 市场预测至 2030 年 - 区域分析 - 按治疗、产品、应用和最终用户
市场调查报告书
商品编码
1494308

北美 dPCR 和 qPCR 市场预测至 2030 年 - 区域分析 - 按治疗、产品、应用和最终用户

North America dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment, Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 97 Pages | 订单完成后即时交付

价格

2022年北美dPCR和qPCR市场估值为35.5108亿美元，预计2030年将达到74.2903亿美元；预计 2022 年至 2030 年复合年增长率为 9.7%。

遗传性疾病和传染病发病率的增加推动北美 dPCR 和 qPCR 市场

根据国家组织关于遗传性疾病或先天性残疾的信息，虽然个体遗传性疾病很少见，但总体而言，被诊断患有遗传性疾病的人超过 15,500 人。美国 MJH 生命科学公司的报告估计，到 2022 年，全球每年有 30 万名新生儿患有镰状细胞疾病，占 ?占全球人口的5%。在美国，它是最常见的遗传疾病之一。此外，每 500 名非裔美国人中就有 1 人患有镰状细胞疾病，且？据美国疾病管制与预防中心 (CDC) 称，其中 12 人中有 1 人患有常染色体隐性突变。 COVID-19 的爆发对聚合酶炼式反应市场的成长产生了重大影响。临床诊断市场不断增长的需求对PCR产业产生了有利的影响。几乎所有诊断测试都使用 RT-PCR 来测试有 COVID-19 症状的人，并且医疗保健专家敦促他们进行诊断测试，而当局尚未认可病毒培养测试。大多数生物技术和製药企业都将精力集中在研发部门，寻找针对 COVID-19 的新化合物或治疗方法。 2022年2月，罗氏将新发表的分子实验室仪器Cobas 5800系统加入其COVID-19 PCR产品组合中，供接受CE认证的国家使用。这些产品包括cobas SARS-CoV-2和甲型/乙型流感检测，以及cobas SARS-CoV-2定性检测。透过在低、中和高容量分子实验室测试需求中提供统一的性能和效率，这些产品拓宽了罗氏诊断的分子产品组合。此外，借助新型紧凑型 Cobas 5800 系统，空间或资源有限的医疗保健组织可以进行全面存取。在由于缺乏资源或空间而无法容纳较大设备的国家或地区，这将带来更好的测试可访问性。

因此，可使用 dPCR 和 qPCR 技术进行诊断和治疗的遗传性疾病和传染病的发生率不断增加，支持了北美 dPCR 和 qPCR 市场的成长。

北美 dPCR 和 qPCR 市场概览

北美 dPCR 和 qPCR 市场分为美国、加拿大和墨西哥。北美是最大的生物技术市场，其中美国占最大的市场份额，其次是加拿大。北美市场的成长归因于生物分析仪器製造商和 PCR 公司对创新产品的需求增加、主要市场参与者的存在以及各个学术和研究机构进行的广泛研发。医疗保健领域对先进方法整合的日益关注、政府和私人促进精准医疗的倡议，以及政府和私人机构为基因组研究提供的大量资金，预计也将刺激北美 dPCR 和 qPCR 的增长并创造非凡的收入北美市场。此外，该国各研究小组的科学进展与该地区在全球市场定位中的成长和主导地位相对应。

北美 dPCR 和 qPCR 市场收入及 2030 年预测（百万美元）

北美 dPCR 和 qPCR 市场细分

北美 dPCR 和 qPCR 市场根据治疗、产品、应用、最终用户和国家进行细分。

根据处理方式，北美 dPCR 和 qPCR 市场分为定量 PCR (qPCR) 和数位 PCR (dPCR)。到 2022 年，数位 PCR (dPCR) 领域将占据更大的份额。

按产品划分，北美 dPCR 和 qPCR 市场分为试剂和耗材、仪器以及软体和服务。 2022 年，试剂和耗材领域占最大份额。

依应用划分，北美 dPCR 和 qPCR 市场分为研究应用、临床应用和法医应用。 2022年，临床应用领域占据最大份额。

按最终用户划分，北美 dPCR 和 qPCR 市场分为医院和诊断中心、製药和生物技术公司、研究实验室和学术机构、法医实验室和临床研究组织。 2022 年，医院和诊断中心细分市场占据最大份额。

根据国家/地区，北美 dPCR 和 qPCR 市场分为美国、加拿大和墨西哥。 2022 年，美国主导北美 dPCR 和 qPCR 市场。

Abbott Laboratories、Thermo Fisher Scientific Inc、Takara Bio Inc、Qiagen NV、Standard BioTools Inc、乐普医疗科技北京有限公司、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc 和 Agilent Technologies Inc 是一些领先公司运营北美dPCR 和qPCR 市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美 dPCR 和 qPCR 市场 - 主要产业动态

  • 市场驱动因素
    • 遗传性疾病和传染病的发生率不断增加
    • 基因合成的投资和资金不断增加
    • PCR 技术的技术进步
  • 市场限制
    • PCR 系统成本高
    • 与 qPCR 相关的技术限制
  • 市场机会
    • 新兴国家越来越多地采用 PCR 方法
  • 未来的趋势
    • 微滴式数位PCR的发展
  • 影响分析：

第 5 章：dPCR 和 qPCR 市场 - 北美市场分析

  • 北美 dPCR 和 qPCR 市场收入，2022 - 2030

第 6 章：北美 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按治疗方式

  • 概述
  • 2022 年和 2030 年北美 dPCR 和 qPCR 市场收入份额（按治疗方式）（%）
  • 定量PCR
  • 数位PCR

第 7 章：北美 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 北美 dPCR 和 qPCR 市场收入份额（按产品），2022 年和 2030 年 (%)
  • 试剂及耗材
  • 仪器
  • 软体与服务

第 8 章：北美 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按应用

  • 概述
  • 2022 年和 2030 年北美 dPCR 和 qPCR 市场收入份额（按应用划分）（%）
  • 研究应用
  • 临床应用
  • 法医应用

第 9 章：北美 dPCR 和 qPCR 市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年北美 dPCR 和 qPCR 市场收入份额（按最终用户划分）（%）
  • 医院和诊断中心
  • 製药和生物技术公司
  • 研究实验室和学术机构
  • 法医实验室
  • 临床研究组织

第 10 章：北美 dPCR 和 qPCR 市场 - 国家分析

    • 北美 dPCR 和 qPCR 市场（按国家）
      • 我们
      • 加拿大
      • 墨西哥

第 11 章：dPCR 和 qPCR 市场-产业格局

  • 概述
  • 北美 dPCR 和 qPCR 市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Standard BioTools Inc
  • Lepu Medical Technology Beijing Co Ltd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc

第 13 章：附录

Product Code: BMIRE00029878

The North America dPCR and qPCR market was valued at US$ 3,551.08 million in 2022 and is expected to reach US$ 7,429.03 million by 2030; it is estimated to grow at a CAGR of 9.7% from 2022 to 2030.

Increasing Incidence of Genetic and Infectious Diseases Drive North America dPCR and qPCR Market

According to the National Organization's information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, they comprise over 15,500 people diagnosed with genetic disorders. In 2022, a report by MJH Life Sciences (US) estimates that 300,000 newborns worldwide are born with sickle cell disease every year, accounting for ? 5% of the global population. In the US, it is one of the most prevalent genetic conditions. Also, 1 in 500 African Americans is affected by sickle cell disease, and ? 1 in 12 of them suffers from the autosomal recessive mutation, according to the CDC. The COVID-19 outbreak had a significant effect on the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market has a favorable effect on the PCR industry. Nearly all diagnostic tests use RT-PCR to test the people having symptoms of COVID-19 and were urged by healthcare experts to undergo a diagnostic test, while the authorities have not endorsed viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These product include the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium-, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Better testing accessibility will result from this in nations or settings where larger equipment cannot be accommodated due to a lack of resources or space.

Thus, increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatments support the growth of the North America dPCR and qPCR market.

North America dPCR and qPCR Market Overview

The North America dPCR and qPCR market in North America is segmented into the US, Canada, and Mexico. North America is the largest market for biotechnology, with the US holding the largest market share, followed by Canada. The market growth in North America is attributed to an increase in the demand for innovative products from bio-analytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes. The increasing focus on advanced method incorporation in healthcare, government and private initiatives for promoting precision medicine, and massive funds from government and private bodies for genomic research are also expected to stimulate the growth and contribute to exceptional revenue generation for the North America dPCR and qPCR market in North America. Additionally, scientific advances made by various research groups in the country correspond to the growth and dominance of the region in the global market positioning.

North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

North America dPCR and qPCR Market Segmentation

The North America dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the North America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the North America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the North America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the North America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the North America dPCR and qPCR market is segmented into segmented into the US, Canada, and Mexico. The US dominated the North America dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the North America dPCR and qPCR market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America dPCR and qPCR Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Incidence of Genetic and Infectious Diseases
    • 4.1.2 Rising Investments and Funds for Gene Synthesis
    • 4.1.3 Technological Advancements in PCR Technologies
  • 4.2 Market Restraints
    • 4.2.1 High Costs of PCR Systems
    • 4.2.2 Technical Limitations Associated with qPCR
  • 4.3 Market Opportunities
    • 4.3.1 Growing Adoption of PCR Methods in Emerging Countries
  • 4.4 Future Trends
    • 4.4.1 Development of Droplet Digital PCR
  • 4.5 Impact Analysis:

5. dPCR and qPCR Market - North America Market Analysis

  • 5.1 North America dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

6. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

  • 6.1 Overview
  • 6.2 North America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • 6.3 Quantitative PCR
    • 6.3.1 Overview
    • 6.3.2 Quantitative PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Digital PCR
    • 6.4.1 Overview
    • 6.4.2 Digital PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

7. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 North America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • 7.3 Reagents & Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents & Consumables: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Software & Services
    • 7.5.1 Overview
    • 7.5.2 Software & Services: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • 8.3 Research Application
    • 8.3.1 Overview
    • 8.3.2 Research Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinical Application
    • 8.4.1 Overview
    • 8.4.2 Clinical Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.4.2.1 North America dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
  • 8.5 Forensic Application
    • 8.5.1 Overview
    • 8.5.2 Forensic Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. North America dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

  • 9.1 Overview
  • 9.2 North America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical and Biotechnology Companies: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Research Laboratories and Academic Institutes
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories and Academic Institutes: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Forensic Laboratories
    • 9.6.1 Overview
    • 9.6.2 Forensic Laboratories: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Clinical Research Organizations
    • 9.7.1 Overview
    • 9.7.2 Clinical Research Organizations: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. North America dPCR and qPCR Market - Country Analysis

    • 10.1.1 North America dPCR and qPCR Market, by Country
      • 10.1.1.1 US
        • 10.1.1.1.1 US : North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 US: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.1.3 US: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.4 US: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.1.4.1 US: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.1.5 US: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.2 Canada
        • 10.1.1.2.1 Canada: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Canada: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Canada: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Canada: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.2.4.1 Canada: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.2.5 Canada: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
      • 10.1.1.3 Mexico
        • 10.1.1.3.1 Mexico: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Mexico: North America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Mexico: North America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Mexico: North America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
        • 10.1.1.3.4.1 Mexico: North America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)
        • 10.1.1.3.5 Mexico: North America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

11. dPCR and qPCR Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in North America dPCR and qPCR Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Takara Bio Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Qiagen NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Standard BioTools Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lepu Medical Technology Beijing Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 F. Hoffmann-La Roche Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Agilent Technologies Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America dPCR and qPCR Market Segmentation
  • Table 2. North America dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US: North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US: North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US: North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada: North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada: North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada: North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada: North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada: North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico: North America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Mexico: North America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Mexico: North America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico: North America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico: North America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Recent Organic Growth Strategies in North America dPCR and qPCR Market
  • Table 19. Recent Inorganic Growth Strategies in the North America dPCR and qPCR Market
  • Table 20. Glossary of Terms, North America dPCR and qPCR Market

List Of Figures

  • Figure 1. North America dPCR and qPCR Market Segmentation, By Country
  • Figure 2. North America dPCR and qPCR Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
  • Figure 6. Quantitative PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Digital PCR: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. North America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
  • Figure 9. Reagents & Consumables: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Instruments: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Software & Services: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
  • Figure 13. Research Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Clinical Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Forensic Application: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
  • Figure 17. Hospitals and Diagnostic Centers: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Pharmaceutical and Biotechnology Companies: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Research Laboratories and Academic Institutes: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Forensic Laboratories: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Clinical Research Organizations: North America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America: North America dPCR and qPCR Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. US : North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Canada: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Mexico: North America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Growth Strategies in North America dPCR and qPCR Market